Nation
World
Politics
Sports
Business
Entertainment
Life
Tech
Science
Opinion
Crime
Health
Oddities

GSK Reports Earnings Wednesday. Investors Are Watching the RSV Vaccine Showdown.

Por: MarketWatch Business January 31, 2024

thumbnail

GSK’s 2023 performance wasn’t as abysmal as that of peers like and , which face steep patent cliffs before the end of the decade. GSK faces its own patent expiry on an important HIV antiviral. However, investor focus is firmly on the company’s new respiratory syncytial virus vaccine, Arexvy, which had a strong launch in 2023. Analysts expect GSK to report earnings of 29 pence per share for the fourth quarter, on sales of £7.6 billion... + full article



Similar News

Ravens, 49ers finish on top of NFL as playoff picture becomes crystal clear

Fox News USA Sports January 08, 2024

The 2023 to a close on Sunday with the final playoff spots getting clinched and teams capping off the year with division titles. The NFC side of the bracket was figured out before the AFC as the Miami Dolphins played the Buffalo Bills for the AFC East division crown and a chance... + más

Was a young girl adopted from Russia capable of murder? | CBS News

The Kids Who Snitched on Their Families Because DARE Told Them To | Slate


Packers vs Bears: The NFL rival that started with a shutout in 1921

Fox News USA Sports December 13, 2023

The rivalry between the and the Chicago Bears is a story that includes shutouts, ejections, cheeseheads and champions.  Born from a 20-0 win in 1921, and further fueled by the first ejection in NFL history, the Packers and Bears remain one of the oldest rivalries in... + más

What Are the Duties of A Trustee? | Forbes

NFL Week 17 playoff picture and clinching scenarios: Bucs win NFC South; Giants clinch wild card | ESPN


MLB playoff projections: Dodgers should be No. 2 seed in NL. Who else is in?

Los Angeles Times USA Sports September 18, 2023

thumbnailClinching the National League West title as early as they did enables the Dodgers to foresee the first step of their postseason with reasonable certainty. The Dodgers will be seeded No. 2 among the six NL playoff teams, behind the East champion Atlanta Braves and in front of the... + más

Dodgers Dugout: This is why the Braves are favored over the Dodgers | Los Angeles Times

Friends and celebrities pay tribute to Lisa Marie Presley: We are heartbroken | CBS News


NBA playoffs 2023: Our insiders dissect the Eastern and Western conference finals

ABC7 USA Sports May 16, 2023

thumbnailbegin Tuesday (8:30 p.m. ET, ), with just four teams remaining in the fight for the NBA title.Of those four teams, however, two made the playoffs through the play-in tournament.The No. 7 seed,who advanced through the play-in tourney, will face the --the No. 1 seed with the... + más

What Are the Duties of A Trustee? | Forbes

Le Krewe du Roi celebrates the state at 58th annual Mardi Gras Ball | The Advocate


World’s first RSV vaccine approved by FDA — breakthrough 60 years in the making

New York Post USA Life May 04, 2023

thumbnailThe Food and Drug Administration on Wednesday approved Arexvy, the world’s first vaccine for RSV, or — a scientific breakthrough 60 years in the making. Manufactured by pharmaceutical giant GSK, the single-dose shot aims to prevent lower respiratory tract disease, caused by... + más

What Are the Duties of A Trustee? | Forbes

After promising trial results for maternal RSV vaccine, Pfizer says it will seek FDA approval this year | CNN


What Are the Duties of A Trustee?

Forbes USA Business March 27, 2023

thumbnailLight Bulbs Concept Shining ETHICS, RESPECT, HONESTY and INTEGRITYgetty Previously, I wrote on in some detail, but did not go into the duties the Trustee of a Trust owes to the Trust’s beneficiary. To summarize, a Trust is an agreement written by the owner of the property,... + más

Selecting The Right Trustee To Manage Your Trust | Forbes

Author Post: Using Land Trusts For Anonymity And Asset Protection | Forbes


FDA Panel Backs GSK’s RSV Vaccine for Older People

Time USA Health March 03, 2023

thumbnailGSK Plc’s vaccine for won the support of a key panel of U.S. regulatory advisers for use in people aged 60 and older, as the drugmaker races against Pfizer Inc. to bring to market the first vaccine for RSV. The panel of 12 outside advisers to the Food and Drug Administration... + más

FDA advisors recommend GSK's RSV vaccine for older adults, but flag potential safety risks | CNBC

GSK vaccine for older adults granted FDA priority review | Fox Business



About iurex | Privacy Policy | Disclaimer |